Slides
Innovative immunotherapy for hypercholesterolaemiaPCSK9 as a therapeutic target to reduce LDL-C and the burden of ASCVDUnmet clinical needs in lipid lowering: Focus on LDL-CInclisiran and the ORION clinical development programPCSK9 inhibition: an overview of therapeutic approachesView all slides »Videos
Lerodalcibep: What does LIBerate-HeFH tell us?
Verve-101: Where are we up to with PCSK9 gene editing?
Apo(a) size and PAD revascularisation outcomes: What’s the link?
Lepodisiran: What progress towards Lp(a) reduction?
View all videos »Events
73rd American College of Cardiology Annual Scientific Session
Event start date: 6 Apr 2024
Atlanta, USA
92nd European Atherosclerosis Society Congress 2024
Event start date: 26 May 2024
Lyon, France
European Society of Cardiology Congress 2024
Event start date: 30 Aug 2024
London, UK, and online
View all events »
Event start date: 6 Apr 2024
Atlanta, USA
92nd European Atherosclerosis Society Congress 2024
Event start date: 26 May 2024
Lyon, France
European Society of Cardiology Congress 2024
Event start date: 30 Aug 2024
London, UK, and online
View all events »